Myla Lai-Goldman
Director/Board Member at WEST PHARMACEUTICAL SERVICES, INC.
Net worth: 7 M $ as of 31/03/2024
Profile
Myla P.
Lai-Goldman was the founder of CancerGuide Diagnostics, Inc. (founded in 2009) where she served as the Chief Executive & Scientific Officer from 2009 to 2010.
She is also the founder of GeneCentric Therapeutics, Inc. (founded in 2011) where she currently holds the title of Executive Chairman.
Additionally, she is the founder of Personalized Science LLC (founded in 2009) and serves as the Managing Partner.
Dr. Lai-Goldman's current job(s) include being an Independent Director at West Pharmaceutical Services, Inc. since 2014.
She is also a Director at Council for Entrepreneurial Development, Qvella Corp., Akoya Biosciences, Inc., Mercy Bioanalytics, Inc., NovoPath LLC, and Hatteras Venture Partners.
In her former positions, Dr. Lai-Goldman served as an Independent Director at Sequenom, Inc. from 2012 to 2016.
She was the Medical Director at the Center for Molecular Biology & Pathology from 1991 to 2004.
She also held the position of Executive VP, Chief Medical & Scientific Officer at Laboratory Corp.
of America Holdings from 1991 to 2008.
Additionally, she worked at Roche Biomedical Laboratories, Inc., National Genetics Institute, Inc., and Viro-Med Laboratories, Inc.Dr. Lai-Goldman obtained a doctorate degree from The Trustees of Columbia University in The City of New York and an undergraduate degree from the University of Pennsylvania.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
23/04/2024 | 18,353 ( 0.03% ) | 7 M $ | 31/03/2024 | |
AKOYA BIOSCIENCES INC
0.04% | 12/06/2023 | 20,000 ( 0.04% ) | 93 800 $ | 31/03/2024 |
Myla Lai-Goldman active positions
Companies | Position | Start |
---|---|---|
WEST PHARMACEUTICAL SERVICES, INC. | Director/Board Member | 17/02/2014 |
AKOYA BIOSCIENCES, INC. | Director/Board Member | 16/09/2021 |
NovoPath LLC
NovoPath LLC Packaged SoftwareTechnology Services NovoPath LLC is a laboratory information systems company based in Bridgewater, NJ. The company has been recognized for innovation and has developed a SaaS-based platform called NovoPath 360 that enables anatomic and clinical pathology labs worldwide to automate, track, simplify, and complete complex cases from heme to derm faster than ever. NovoPath LIS is the most intuitive and robust laboratory information system that deploys automation, generates insightful patient reports, facilitates workflow adjustments, and helps drive innovation. The CEO of the company is Promise Okeke. | Director/Board Member | - |
Qvella Corp.
Qvella Corp. Medical SpecialtiesHealth Technology Qvella Corp provides molecular diagnostics. It develops a differentiated technology for pathogen detection by direct sampling of boldily fluids without the need for culturing or time consuming sample processing. The company was founded by Tino Alavie in 2009 and is headquartered in Richmond Hill, Canada. | Director/Board Member | - |
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Director/Board Member | 24/04/2023 |
Council for Entrepreneurial Development
Council for Entrepreneurial Development Miscellaneous Commercial ServicesCommercial Services Council for Entrepreneurial Development provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers. Its services and programs include connections to capital, venture mentoring, and signature conferences empower member companies to go further. The company was founded in 1984 and is headquartered in Durham, NC. | Director/Board Member | - |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Founder | 01/01/2011 |
Personalized Science LLC
Personalized Science LLC Miscellaneous Commercial ServicesCommercial Services Personalized Science LLC operates as a consulting company. It offers consulting services, The company was founded by Myla Lai-Goldman in 2009 and is headquartered in Chapel Hill, NC. | Founder | 01/01/2009 |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Private Equity Investor | 01/08/2011 |
Former positions of Myla Lai-Goldman
Companies | Position | End |
---|---|---|
░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░░░ ░░░░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░ ░░░░░ ░░░░░░░░░ | ░░░░░ ░░░░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - |
Training of Myla Lai-Goldman
The Trustees of Columbia University in The City of New York | Doctorate Degree |
University of Pennsylvania | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 3 |
---|---|
LABORATORY CORPORATION OF AMERICA HOLDINGS | Health Services |
WEST PHARMACEUTICAL SERVICES, INC. | Health Technology |
AKOYA BIOSCIENCES, INC. | Health Technology |
Private companies | 13 |
---|---|
Sequenom, Inc.
Sequenom, Inc. Medical SpecialtiesHealth Technology Sequenom, Inc. engages in the provision of early patient management information. It develops and commercializes molecular diagnostic testing services that serve women's health and oncology markets. The company was founded by Hubert Koester and Charles R. Cantor in October 09, 1996 and is headquartered in Burlington, NC. | Health Technology |
CancerGuide Diagnostics, Inc.
CancerGuide Diagnostics, Inc. Medical/Nursing ServicesHealth Services CancerGuide Diagnostics was founded and launched by experienced individuals, passionate about fulfilling the unmet needs in current cancer care and drug development. CancerGuide Diagnostics'™ vision is to dramatically improve the management of cancer by providing physicians with advanced molecular diagnostics that enable individualized treatment decisions. CancerGuide is a singularly focused diagnostic product and services company that is actively licensing high-value, novel technology that may improve the quality of life for those living with cancer. Through its collaboration with Laboratory Corporation of America® Holdings (LabCorp®), CancerGuide provides an innovative development-to-commercial market platform for emerging molecular oncology diagnostic technologies. In addition to its internal diagnostic development programs, CancerGuide provides companion diagnostic development services, including tumor profiling and signature development services, to pharmaceutical and biotechnology companies to help maximize the efficiency and effectiveness of cancer therapy pipelines. | Health Services |
GeneCentric Therapeutics, Inc.
GeneCentric Therapeutics, Inc. Medical SpecialtiesHealth Technology GeneCentric Therapeutics, Inc. develops and commercializes molecular diagnostic assays. Its product enables oncologists and patients to make more informed, individualized treatment decisions. The firm's product CSP identifies cancer subtypes that enable drug developers to meet the growing demand for precision medicines, and provide clinicians the information they need to make individualized treatment decisions. The company was founded by David Neil Hayes, Charles M. Perou, and Myla P. Lai-Goldman in 2011 and is headquartered in Durham, NC. | Health Technology |
Roche Biomedical Laboratories, Inc. | Health Technology |
National Genetics Institute, Inc.
National Genetics Institute, Inc. Chemicals: SpecialtyProcess Industries Part of Laboratory Corp. of America Holdings, National Genetics Institute, Inc. provides hepatitis C testing and other laboratory services. The private company is based in Los Angeles, CA. The company was founded by Andrew J. Conrad, Michael A. Aicher. National Genetics Institute was acquired by Laboratory Corp. of America Holdings on August 01, 2000. | Process Industries |
Hatteras Venture Partners
Hatteras Venture Partners Investment ManagersFinance Hatteras Venture Partners (Hatteras Venture) is venture capital firm founded in 2000 by Clay B. Thorp and John Crumpler. The firm is headquartered in Durham, North Carolina. | Finance |
Council for Entrepreneurial Development
Council for Entrepreneurial Development Miscellaneous Commercial ServicesCommercial Services Council for Entrepreneurial Development provides an interactive forum for entrepreneurs, investors, service professionals, academicians, researchers and public policy makers. Its services and programs include connections to capital, venture mentoring, and signature conferences empower member companies to go further. The company was founded in 1984 and is headquartered in Durham, NC. | Commercial Services |
Viro-Med Laboratories, Inc.
Viro-Med Laboratories, Inc. Miscellaneous Commercial ServicesCommercial Services Viro-Med Laboratories, Inc. engages in the provision of diagnostic testing in virology, molecular biology, serology, microbiology, mycology, and mycobacteriology. The company was established in 1982 and is headquartered in Minneapolis, MN. | Commercial Services |
Center for Molecular Biology & Pathology | |
Personalized Science LLC
Personalized Science LLC Miscellaneous Commercial ServicesCommercial Services Personalized Science LLC operates as a consulting company. It offers consulting services, The company was founded by Myla Lai-Goldman in 2009 and is headquartered in Chapel Hill, NC. | Commercial Services |
Qvella Corp.
Qvella Corp. Medical SpecialtiesHealth Technology Qvella Corp provides molecular diagnostics. It develops a differentiated technology for pathogen detection by direct sampling of boldily fluids without the need for culturing or time consuming sample processing. The company was founded by Tino Alavie in 2009 and is headquartered in Richmond Hill, Canada. | Health Technology |
Mercy Bioanalytics, Inc.
Mercy Bioanalytics, Inc. Pharmaceuticals: MajorHealth Technology The American company was founded in 2018 by Joseph Sedlak and Paul W. Blavin, and Dawn R. Mattoon has been the CEO of the company since 2022. Mercy Bioanalytics utilizes the patented Mercy Halo liquid biopsy platform to detect stage I cancer, which is most treatable, by analyzing single extracellular vesicles (EVs) that carry unique cancer signatures from their parent cells. The company's initial focus is on the early detection of ovarian and lung cancers, which are difficult to detect and often go undetected until it is too late to cure. The Mercy Halo test makes early-stage cancer detection 100,000 times easier by analyzing EVs found in blood that are specific to their parent cells. | Health Technology |
NovoPath LLC
NovoPath LLC Packaged SoftwareTechnology Services NovoPath LLC is a laboratory information systems company based in Bridgewater, NJ. The company has been recognized for innovation and has developed a SaaS-based platform called NovoPath 360 that enables anatomic and clinical pathology labs worldwide to automate, track, simplify, and complete complex cases from heme to derm faster than ever. NovoPath LIS is the most intuitive and robust laboratory information system that deploys automation, generates insightful patient reports, facilitates workflow adjustments, and helps drive innovation. The CEO of the company is Promise Okeke. | Technology Services |
- Stock Market
- Insiders
- Myla Lai-Goldman